Home
About
Overview
Sharing Data
ORCID
Help
History (12)
ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
Inosine Diphosphate
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest.
Biomesh placement in laparoscopic repair of paraesophageal hernias.
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol. 2002 Jun; 9(5):500-4.
View in:
PubMed
subject areas
Adenocarcinoma
Adenoviridae
Animals
Combined Modality Therapy
Disease Progression
DNA-Binding Proteins
Early Growth Response Protein 1
Esophageal Neoplasms
Gene Expression Regulation, Neoplastic
Genetic Therapy
Genetic Vectors
Humans
Immediate-Early Proteins
Mice
Mice, Nude
Promoter Regions, Genetic
Radiotherapy
Transcription Factors
Transplantation, Heterologous
Treatment Outcome
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha
authors with profiles
Ralph Weichselbaum
Mitchell Posner
Nora Jaskowiak